I期非小细胞肺癌术后持续吸烟影响长期生存
基于退伍军人健康数据库的回顾性队列研究,纳入2006-2016年接受手术的临床I期NSCLC患者7489例,定义术后1年仍吸烟为持续吸烟。术后1年持续吸烟与更短的总生存显著相关(aHR 1.291;95%CI 1.197-1.392;P<.001),但与无病生存无显著关联(aHR 0.989;95%CI 0.884-1.106;P=.84)。
要点
- 术后1年持续吸烟与I期NSCLC术后总生存显著缩短相关。
- 持续吸烟与无病生存无显著关联(aHR 0.989;P=.84)。
- 术后应持续评估吸烟习惯,因其对长期结局影响显著。
核心结论
- I期NSCLC术后持续吸烟常见,且与更差的总生存相关。
- 持续吸烟与无病生存无显著关联。
研究设计与样本
- 回顾性队列研究,使用退伍军人健康管理局(VHA)独特汇编数据集。
- 纳入2006-2016年接受手术的临床I期NSCLC患者7489例。
主要发现
- 手术时吸烟者4562例(60.9%),其中2648例(58.0%)术后1年仍吸烟。
- 手术时不吸烟者2927例(39.1%),其中573例(19.6%)术后1年复吸。
- 术后1年持续吸烟与总生存缩短显著相关(aHR 1.291;95%CI 1.197-1.392;P<.001)。
- 持续吸烟与无病生存无显著关联(aHR 0.989;95%CI 0.884-1.106;P=.84)。
临床怎么用
- 术后应持续评估患者吸烟习惯。
- 鉴于持续吸烟对长期结局的显著影响,应重视术后戒烟干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Smoking at the time of surgical treatment for lung cancer increases the risk for perioperative morbidity and mortality. The prevalence of persistent smoking in the postoperative period and its association with long-term oncologic outcomes are poorly described. RESEARCH QUESTION: What is the relationship between persistent smoking and long-term outcomes in early-stage lung cancer after surgical treatment? STUDY DESIGN AND METHODS: We performed a retrospective cohort study using a uniquely compiled Veterans Health Administration dataset of patients with clinical stage I non-small cell lung cancer (NSCLC) undergoing surgical treatment between 2006 and 2016. We defined persistent smoking as individuals who continued smoking 1 year after surgery and characterized the relationship between persistent smoking and disease-free survival and overall survival. RESULTS: This study included 7,489 patients undergoing surgical treatment for clinical stage I NSCLC. Of 4,562 patients (60.9%) who were smoking at the time of surgery, 2,648 patients (58.0%) continued to smoke at 1 year after surgery. Among 2,927 patients (39.1%) who were not smoking at the time of surgical treatment, 573 (19.6%) relapsed and were smoking at 1 year after surgery. Persistent smoking at 1 year after surgery was associated with significantly shorter overall survival (adjusted hazard ration [aHR], 1.291; 95% CI, 1.197-1.392; P < .001). However, persistent smoking was not associated with inferior disease-free survival (aHR, 0.989; 95% CI, 0.884-1.106; P = .84). INTERPRETATION: Persistent smoking after surgery for stage I NSCLC is common and is associated with inferior overall survival. Providers should continue to assess smoking habits in the postoperative period given its disproportionate impact on long-term outcomes after potentially curative treatment for early-stage lung cancer.
引用
- Heiden BT, Eaton DB, Chang SH, et al. The Impact of Persistent Smoking After Surgery on Long-term Outcomes After Stage I Non-small Cell Lung Cancer Resection. Chest. 2021. PMID: 34919892. doi:10.1016/j.chest.2021.12.634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。